PSTV

#3614
PLUS THERAPEUTICS, Inc. Common Stock
0.30
0.00%
版块:
基础:
利润货币:
日范围
0.30
0.30
年范围
0.16
2.29
日变化
0.00%
每月变动
+25.00%
6个月变化
-40.00%
年变化
-55.88%
前一天收盘价
0.30
Open
0.30
Bid
Ask
Low
0.30
High
0.30
交易量
7
Open full chart

Financials

Overview 声明 Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

PLUS THERAPEUTICS Inc

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®.

新闻